Author Description

This report by the World Health Organization (WHO) focuses on pediatric drug optimization for antibiotics, highlighting the need to improve formulations for children. It addresses the significant gap in drug development for children compared to adults, emphasizing the urgency due to bacterial infections being a leading cause of mortality among children under five. The report outlines the objectives, methods, and discussions from a meeting held in late 2022, aiming to accelerate access to optimal formulations. The WHO's Global Accelerator for Paediatric Formulations Network (GAP-f) is spotlighted as a key initiative in prioritizing and developing essential drug formulations for children. The publication is intended for public health organizations, practitioners, and stakeholders involved in pediatric healthcare, providing guidance on antibiotic stewardship and addressing antimicrobial resistance challenges.